Search clinical trials for: AbobotulinumtoxinA (ABO)

Total 3387 results

IRCCS Eugenio Medea

Recruiting

Pragmatic Abilities in Children With Acquired Brain Injury (ABIabc)

Acquired Brain Injury | Pragmatic Communication Disorder

Italy
Aboca Spa Societa' Agricola
Latis S.r.l.; Fondazione Edmund Mach

Completed

ABO-GLYC in Type 2 Diabetes

Type2 Diabetes

Italy
Brazilan Center for Studies in Dermatology

Completed

Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses

Skin Wrinkling

Brazil
Abeona Therapeutics, Inc

Terminated

A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101

Mucopolysaccharidosis III-B

United States, Germany, France
Kafrelsheikh University

Completed

Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft

Implant | Ridge Augmentation | Autogenous Tooth Graft

Egypt
St Joseph University, Beirut, Lebanon

Unknown

The Impact of Botulinum Toxin on Brow Height and Morphology: A Randomized Controlled Trial

Brow Lifting

Lebanon
Intermountain Health Care, Inc.

Completed

Test of Chamber Pressure to Divers and Chamber Attendants (TOP-DIVER)

Traumatic Brain Injury

United States
Amgen

Completed

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Advanced Renal Cell Carcinoma
Amgen

Completed

Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer

Metastatic Colorectal Cancer
Ultragenyx Pharmaceutical Inc
Abeona Therapeutics, Inc

Terminated

Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Mucopolysaccharidosis III | Sanfilippo Syndrome | MPS IIIA | Sanfilippo A

United States, Spain, Australia
Bausch & Lomb Incorporated

Completed

Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

Cataract

Philippines
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Platysmal Bands

United States
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
Neurology Center of New England P.C.
Ipsen

Unknown

" Treating MS Patients With Lower Extremity Spasticity Using Dysport"

Multiple Sclerosis | Spasticity, Muscle

United States
Cairo University

Unknown

Study of the Relationship Between Blood Groups,RH and Skeletal Malocclusion : a Cross Sectional Study

Class III Malocclusion | Class II Malocclusion
Ultragenyx Pharmaceutical Inc
Abeona Therapeutics, Inc

Active, not recruiting

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Mucopolysaccharidosis III | Sanfilippo Syndrome | MPS IIIA | Sanfilippo A

United States, Australia, Spain
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

COVID-19

Indonesia
Mohamed Tahar Maamouri University Hospital

Completed

Clinical Performance of Therapeutic Use of BTX for Bruxism (BTX)

Pain | Bruxism | Myofascial Pain Syndrome | Myofascial Trigger Point Pain

Tunisia
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
Ipsen

Completed

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Glabellar Frown Lines

Germany, France
Ipsen

Completed

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Cervical Dystonia

France, Belgium, Czechia, Australia, Poland, Portugal, Ukraine, Hungary, Russian Federation, Austria, Germany
Seoul National University Hospital
Ipsen; Medical Research Collaborating Center, Seoul, Korea

Completed

A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia

Cervical Dystonia

Korea, Republic of
National Cheng-Kung University Hospital

Completed

An Ankle-foot Orthosis Improves Gait Performance and Satisfaction in Stroke Patients

Gait Analysis

Taiwan
Galderma R&D

Completed

Subject Satisfaction With AbobutulinumtoxinA Treatment (DREAM)

Glabellar Frown Lines

United States
Abbott

Completed

Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

HCV Infection

United States
AbbVie

Completed

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Renal Impairment

United States, New Zealand
Yale University

Completed

Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches

Refractory Migraine

United States
AbbVie

Completed

A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis (EXPEDITION-8)

Hepatitis C Virus (HCV)

United States, Bulgaria, Canada, Czechia, France, Greece, Hungary, Ireland, Israel, Italy, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom, Vietnam
AbbVie

Approved for marketing

Expanded Access to Glecaprevir/ Pibrentasvir

Hepatitis C Virus Infection

Slovenia
Medical University of Graz

Completed

Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients

Cataract | Spherical Aberrations | Intraocular Lenses | Depth of Focus

Austria
AbbVie

Completed

Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function

Hepatic Impairment

United States, New Zealand
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Recurrent Genital Herpes Simplex Type 2

New Zealand
VA Greater Los Angeles Healthcare System
Ipsen

Completed

Abobotulinumtoxina Efficacy in Post-Traumatic Headache

Post-Traumatic Headache

United States
Yale University
Ipsen

Terminated

Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain

Lower Back Pain

United States
AbbVie

Completed

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4) (ENDURANCE-4)

Hepatitis C Virus
Kristina Tedroff
Karolinska University Hospital; Danderyd Hospital

Terminated

Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial (BATCP)

Pain | Cerebral Palsy, Spastic

Sweden
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Hepatitis C Virus (HCV)

Brazil
Texas Woman's University
Baylor Research Institute

Completed

Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.

Stroke | Hemiplegia | Hemiparesis | Foot Drop | CVA

United States
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection (ENDURANCE-2)

Chronic Hepatitis C Virus (HCV) Infection
University Hospitals Cleveland Medical Center

Terminated

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

Scar

United States
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (EXPEDITION-4)

Chronic Hepatitis C Virus (HCV) Infection
Abalonex, LLC

Not yet recruiting

Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury | Cerebral Edema
Karolinska Institutet

Withdrawn

Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery (HODiVA)

Diabetes | Peripheral Arterial Disease | Arterial Occlusive Disease

Sweden
Active Biotech AB

Completed

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Denmark, Sweden
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) (EXPEDITION-2)

Hepatitis C Virus Infection | Chronic Hepatitis C | Human Immunodeficiency Virus Infection | Compensated Cirrhosis and Non-cirrhotics
University of Central Florida

Terminated

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Raynaud Phenomenon

United States
Emory University
Ipsen

Completed

Dysport for the Treatment of OMD

Tardive Dystonia | Oral Dystonia

United States
Clinical Testing of Beverly Hills
Galderma R&D

Active, not recruiting

Dysport Dose-Ranging Treatment of Platysmal Bands

Platysma Bands

United States
Galderma R&D

Completed

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Glabellar Frown Lines

United States
AbbVie

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Chronic Hepatitis C | Hepatitis C Virus | HCV | Direct-Acting Antiviral Agent (DAA)-Experienced

3

Subscribe